Pancreatic cancer is one of the most aggressive diseases among solid tumors.Most patients are diagnosed with advanced or metastatic disease and are characterized by poor chemosensitivity.Therefore,earlier diagnosis an...Pancreatic cancer is one of the most aggressive diseases among solid tumors.Most patients are diagnosed with advanced or metastatic disease and are characterized by poor chemosensitivity.Therefore,earlier diagnosis and novel therapeutic possibilities for pancreatic cancer patients are urgently needed.Liquid biopsy is an emerging technology that allows the noninvasive sampling of tumor material.Nowadays,liquid biopsy has shown promising results as diagnostic,prognostic and predictive biomarkers,but it has not yet been universally adopted into regular use by clinicians.In this review,we describe different components of liquid biopsy,especially circulating tumor cells,circulating tumor DNA and exosomes and their potential clinical utility for pancreatic cancer patients.展开更多
文摘Pancreatic cancer is one of the most aggressive diseases among solid tumors.Most patients are diagnosed with advanced or metastatic disease and are characterized by poor chemosensitivity.Therefore,earlier diagnosis and novel therapeutic possibilities for pancreatic cancer patients are urgently needed.Liquid biopsy is an emerging technology that allows the noninvasive sampling of tumor material.Nowadays,liquid biopsy has shown promising results as diagnostic,prognostic and predictive biomarkers,but it has not yet been universally adopted into regular use by clinicians.In this review,we describe different components of liquid biopsy,especially circulating tumor cells,circulating tumor DNA and exosomes and their potential clinical utility for pancreatic cancer patients.
